Skip to main content

Utah Medical Products Inc

corporate_fare Company Profile

Utah Medical Products Inc

UTMD·NASDAQ·Healthcare·CIK 0000706698

Utah Medical Products, Inc. (UTMD) produces high-quality, cost-effective medical devices primarily focused on improving patient safety and outcomes. The company's success stems from identifying clinician and patient needs, developing economical solutions that achieve premarketing regulatory approval, reliably manufacturing devices, and then selling them through its own direct channels in established markets or through partnerships with other distribution companies. UTMD integrates engineering and technical disciplines including electronics, software, mechanical assembly and packaging, instrumentation, plastics processing, and materials to create differentiated devices that offer significant improvements in patient safety, clinical outcomes, and/or total cost compared to existing clinical methods. For labor-saving devices, this also leads to improved overall healthcare and reduced complication risks. UTMD markets a wide array of medical devices for critical care areas, specifically the neonatal intensive care unit (NICU), labor and delivery (L&D) department, and women's health centers within hospitals, as well as to outpatient clinics and physician's offices. Domestically, UTMD's medical devices are sold directly to clinical end-user facilities or to designated stocking distributors for medical facilities.

Utah Medical Products Inc (NASDAQ:UTMD) is a publicly traded company in the Healthcare sector. Wiseek monitors UTMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Q1 2026 Earnings Detail Revenue & EPS Decline, Strong Cash Maintained
  • Utah Medical Products Reports Double-Digit Q1 Revenue and EPS Decline
  • UTMD Q1 Revenue Plunges 10.2%, EPS Down 11% on Lost Distributor Sales
  • Utah Medical Products Reports 2025 Earnings Decline, Projects 2026 EPS Growth Amidst Strategic Shifts
  • UTMD Reports 2025 Earnings Miss, Boosts Dividends Amidst Significant Share Buybacks

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$38.52M
Net Income
$11.29M
Diluted EPS
$3.48
Op. Cash Flow
$14.69M
Free Cash Flow
$14.32M
Gross Profit
$22M
Operating Income
$11.4M
Cash & Equivalents
$85.76M
Total Debt
$0
Debt / Equity
0.00×
Net Margin
29.3%
Shares Outstanding
3.19M sh
Source: 10-K · filed 2026-03-27 · accession 0001096906-26-000395
Browse all tickers starting with U →
$67.84
52-week range · as of 2026-05-12 $52 – $71.81
Market cap
$216M
Volume
5K (0.5× avg)
3-mo avg 9.6K
Live data · 2026-06-14 03:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed UTMD - Latest Insights

UTMD
May 12, 2026, 3:52 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $63.86
Real-time Price: $67.84 info
Change: +$3.98 (+6%) info
Market Cap: $216.004M info
UTMD
Apr 23, 2026, 3:49 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $67.46
Real-time Price: $67.84 info
Change: +$0.380 (+0.56%) info
Market Cap: $216.004M info
UTMD
Apr 23, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
7
Price at Filing: $69.63
Real-time Price: $67.84 info
Change: -$1.79 (-3%) info
Market Cap: $216.004M info
UTMD
Mar 27, 2026, 5:23 PM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $61.54
Real-time Price: $67.84 info
Change: +$6.30 (+10%) info
Market Cap: $216.004M info
UTMD
Jan 29, 2026, 3:11 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $60.84
Real-time Price: $67.84 info
Change: +$7.00 (+12%) info
Market Cap: $216.004M info